Edward J. Bedrick

Affiliations: 
University of New Mexico, Albuquerque, NM, United States 
Area:
Statistics
Google:
"Edward Bedrick"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bedrick EJ. (2019) Data Reduction Prior to Inference: Are There Consequences of Comparing Groups Using a t-test Based on Principal Component Scores? Biometrics
Huang S, Hu C, Bell ML, et al. (2018) Regularized continuous-time Markov Model via elastic net. Biometrics
Dodd AB, Ling JM, Bedrick EJ, et al. (2018) Spatial distribution bias in subject-specific abnormalities analyses. Brain Imaging and Behavior
Mayer AR, Dodd AB, Ling JM, et al. (2017) An evaluation of Z-transform algorithms for identifying subject-specific abnormalities in neuroimaging data. Brain Imaging and Behavior
Bedrick EJ, Hund L. (2016) An approach for quantifying small effects in regression models. Statistical Methods in Medical Research
Guo Y, Kenney SR, Cook LS, et al. (2015) A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Xu L, Bedrick EJ, Hanson T, et al. (2014) A Comparison of Statistical Tools for Identifying Modality in Body Mass Distributions Journal of Data Science. 12: 175-196
Erhardt EB, Bedrick EJ. (2014) Inference for stable isotope mixing models: A study of the diet of dunlin Journal of the Royal Statistical Society. Series C: Applied Statistics. 63: 579-593
Bedrick EJ. (2014) Two useful reformulations of the hazard ratio American Statistician. 68: 36-41
Harvey RC, Kang H, Roberts KG, et al. (2013) Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (“Ph-like” or “BCR-ABL1-Like”) Signature For Therapeutic Targeting and Clinical Intervention Blood. 122: 826-826
See more...